🇺🇸 FDA
Pipeline program

oral entecavir 0.5mg daily and adefovir 10mg daily for 144 weeks

MOH-07

Approved small_molecule active

Quick answer

oral entecavir 0.5mg daily and adefovir 10mg daily for 144 weeks for Chronic Hepatitis B is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Chronic Hepatitis B
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials